Breast milk gives certain gut bacteria a head start
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Nov-2026 03:16 ET (4-Nov-2026 08:16 GMT/UTC)
The American Cancer Society has awarded an $879,000 Research Scholar Grant to Panneerdoss Subbarayalu, PhD, assistant professor/research in the Department of Cell Systems and Anatomy at the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas at San Antonio (UT San Antonio). The four-year grant will support groundbreaking research at Greehey Children’s Cancer Research Institute to develop a new targeted therapy for osteosarcoma, the most common type of bone cancer in children and adolescents.
AI models – for example, those used for cancer detection – are trained on patients’ health data. Even the mere fact that personal data has been incorporated into a model can have negative consequences for those affected if this information falls into the wrong hands. In “Nature”, a research team now shows that, using the right methods, this sensitive information can be extracted from models far more effectively than previously thought.
Researchers at Umeå University show that the protein METTL3 helps breast cancer cells spread. By regulating the release of molecules, METTL3 makes it easier for tumors to invade surrounding tissue and form metastases. The discovery reveals a previously unknown function of METTL3 and could influence future cancer treatments. The study has been published in Science Advances.
Although lung cancer is often linked to environmental exposures and acquired mutations, some patients develop multiple independent tumors, suggesting a potential role for inherited genetic susceptibility. While the contribution of germline pathogenic variants (GPVs) in several tumors is studied, their significance in lung cancer remains unknown. Now, researchers have explored the genetic basis of multiple primary lung cancers, offering insights into novel BRCA2 GPVs which could serve as targets for therapeutic strategies.
Researchers have engineered a multifunctional gallium-doped bioactive glass that selectively kills osteosarcoma cells and prevents bacterial infections while promoting bone regeneration. By localized delivery of gallium ions, this innovative biomaterial disrupts iron metabolism in cancer cells, triggering programmed cell death without harming healthy bone tissue. It simultaneously provides a robust defense against hospital-acquired pathogens like Pseudomonas aeruginosa.
Researchers at the University of Colorado Anschutz have found that healthy yet sedentary individuals show a significant, coordinated drop in muscle mitochondrial function that may precede the development of major diseases like cancer, diabetes, and Alzheimer’s.